It’s not easy to make public health decisions without access to good data. And epidemiologists and public health workers for Native American communities say they’re often in the dark because state and federal agencies restrict their access to the latest numbers.
Lykos cuts team by 75%, vows to keep MDMA program despite FDA veto
Lykos will be culling 75% of its workforce as it continues to work on the MDMA therapy. Image credit: Getty Images / mathisworks Lykos Therapeutics
August 16, 2024